🇮🇳 Sotyktu in India

Sotyktu (DEUCRAVACITINIB) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Sotyktu in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in India

Frequently asked questions

Is Sotyktu approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Sotyktu in India?

Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.